Mitoxantrone
Mitoxantrone
Mitoxantrone (pronunciation: /maɪˈtɒksænˌtroʊn/) is a type of anthracenedione antineoplastic agent used in the treatment of certain types of cancer, including leukemia, breast cancer, and prostate cancer. It is also used to treat multiple sclerosis.
Etymology
The term "Mitoxantrone" is derived from the chemical name 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]]amino-9,10-anthracenedione dihydrochloride.
Usage
Mitoxantrone works by intercalating into the DNA and producing both single and double strand breaks, as well as interstrand crosslinks. This results in an inhibition of DNA replication and RNA synthesis.
Side Effects
Common side effects of Mitoxantrone include nausea, hair loss, and fatigue. More serious side effects may include heart disease, leukemia, and infections due to low blood cell counts.
Related Terms
- Anthracycline: A class of drugs that are structurally related to Mitoxantrone and are also used as antineoplastic agents.
- Doxorubicin: An anthracycline drug used in cancer chemotherapy that is structurally similar to Mitoxantrone.
- Daunorubicin: Another anthracycline drug used in cancer chemotherapy that is structurally similar to Mitoxantrone.
See Also
External links
- Medical encyclopedia article on Mitoxantrone
- Wikipedia's article - Mitoxantrone
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski